Vitiligo and insulin resistance as a component of
metabolic syndrome: an analysis

Anna Tekielak; Kornelia Pietrauszka; Bartosz Miziołek; Beata Bergler-Czop

doi:10.5114/ada.2023.126871

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2023
vol. 40

Send email

Copy url:

abstract:

Review paper

Vitiligo and insulin resistance as a component of metabolic syndrome: an analysis

Anna Tekielak

¹

,

Kornelia Pietrauszka

²

,

Bartosz Miziołek

³

,

Beata Bergler-Czop

³

Students’ Scientific Association at the Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
Department of Dermatology, Andrzej Mielęcki Independent Public Clinical Hospital of the Silesian Medical University, Katowice, Poland
Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Adv Dermatol Allergol 2023; XL (4): 529-533

DOI: https://doi.org/10.5114/ada.2023.126871

Online publish date: 2023/06/12

View full text Get citation

There have been many studies on the association between vitiligo and metabolic syndrome, while only few scientific papers on vitiligo and insulin resistance. In recent years, there have been significant developments in research to trace and understand the aetiology of both conditions. In this article we have analysed pathophysiological mechanisms and the association of insulin resistance (as a component of metabolic syndrome) and vitiligo.

keywords:

Vitiligo and insulin resistance as a component of metabolic syndrome: an analysis

Anna Tekielak 1 , Kornelia Pietrauszka 2 , Bartosz Miziołek 3 , Beata Bergler-Czop 3

vitiligo, insulin resistance, metabolic syndrome

Anna Tekielak

¹

,

Kornelia Pietrauszka

²

,

Bartosz Miziołek

³

,

Beata Bergler-Czop

³